0001193125-26-342307 Sample Contracts
non-qualified stock OPTION AGREEMENT UNDER the DAMORA THERAPEUTICS, INC. 2022 inducement PLANNon-Qualified Stock Option Agreement • August 10th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Damora Therapeutics, Inc. 2022 Inducement Plan as amended through the date hereof (the “Plan”) and this Stock Option Agreement (the “Agreement”), Damora Therapeutics, Inc. (the “Company”) hereby grants to the Grantee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of Ordinary Shares, par value $0.00001 per share (the “Shares”), of the Company specified above at the Option Exercise Price per Option Share specified above subject to the terms and conditions set forth in the Agreement and in the Plan. This Stock Option has been granted as an inducement pursuant to Rule 5635(c)(4) of the Marketplace Rules of NASDAQ Stock Market, Inc. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the U.S. Internal Revenue Code of 1986, as amended. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified
RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE DAMORA THERAPEUTICS, INC.Restricted Stock Unit Award Agreement • August 10th, 2026 • Damora Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Damora Therapeutics, Inc. 2022 Inducement Plan as amended through the date hereof (the “Plan”), Damora Therapeutics, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one Ordinary Share, par value $0.00001 per share (the “Shares”) of the Company. This Award has been granted as an inducement pursuant to Rule 5635(c)(4) of the Marketplace Rules of NASDAQ Stock Market, Inc.